Highlights of the important and interesting in the world of healthcare:
And the PHR winner is… The Wall Street Journal tested three leading online personal health record systems — Google Health, Microsoft’s HealthVault and WebMD’s Health Manager. None of the three emerged as a clear winner, though the Journal concluded that PHRs offer “a remarkable value for a free application.”
Celgene could become a biopharma giant. Now that Celgene has wrapped up its $3 billion-plus buyout of Abraxis BioScience, Celgene shares are trading near $60, and observers think the combo eventually will transform the company into a “biopharmaceutical giant,” according to FiercePharma.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Health reform prompts doctor evolution. Health system reform, economic factors and other trends are expected to speed consolidation of health insurers and hospitals, leaving physicians to figure out how they should adapt, reports American Medical News.
Psychiatrists get the most drug company payments. ProPublica’s Dollars for Docs database launched last week has yielded an interesting statistic: There are more psychiatrists collecting payments from the pharma industry than any other type of specialist, according to FiercePharma.
Top biopharma transgressors make list. A biotech executive who faked cancer to avoid trial. A researcher who lied about a major stem cell breakthrough. A former CEO charged with sexual harassment. FiercePharma lists of the most notorious people in biotech and pharma.
Telemedicine picks up as costs fall. With costs falling and video quality rapidly improving, more healthcare providers are taking a serious look at videoconferencing for telemedicine, according to a report from Frost & Sullivan, FierceHealthIT reports.
